PROVIDER PROFILE · NPI 1245364975

Jeffrey Gold

PsychiatryNew London, CTI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$17K

Distinct drugs

Brand share

19.7%

Top prescribed drugs

Clozapine16 claims

Clonazepam15 claims

Propranolol Hcl15 claims

Risperidone Microspheres14 claims

Quetiapine Fumarate11 claims

QUALITY · MIPS · 2024

Final MIPS score

90.4

Quality

83.4

Cost

75.9

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.65%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 070007

Hospital

REFERRAL NETWORK

Where Jeffrey Gold's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
HEALTH CARE CHOICES NY INC	23	238
Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ	12	22

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history